Dolutegravir, Second Generation Integrase Inhibitor: A New Hope for HIV Patients
more addition to this rigorous exercise is dolutegravir drug. It is a recent integrase inhibitor approved by the United States of Food and Drug Administration (USFDA
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
more addition to this rigorous exercise is dolutegravir drug. It is a recent integrase inhibitor approved by the United States of Food and Drug Administration (USFDA
Objective: Integrase (IN) is an enzyme essential for HIV-1 replication that has been a target of antiretroviral drug therapy. Since emerging HIV-1 variants have frequently become clinically resistant ... antiretroviral…
series of novel pyrimidone analogues have been designed and synthesized as HIV-1 integrase (IN) inhibitors. This study demonstrated that introducing a substituent in the N1-position of the pyrimidone ... displace…
integrase is a fascinating target for designing of novel HIV-1 Integrase inhibitors. Due to the development of resistance by the use of already developed inhibitors the novel inhibitors
chloro n-(4-oxopyrimidine-2-yl)-2v mercapto benzene sulfonamides. This series of integrase inhibitors were synthesized to assess their potential against HIV. The multiple linear regression analysis
Herein, we report the synthesis, evaluation for HIV integrase (IN) inhibition and
inhibition of the HIV-1 integrase to develop anti-HIV agents. The categories are Oligonucleotides, Curcumin Analogues, Polyhydroxylated Aromatic Compounds, Diketo Acid,) Caffeoyl-based Inhibitors, Hydrazides and Amides…
reverse transcriptase inhibitors, Protease Inhibitors, Nucleoside reverse transcriptase inhibitors, Entry and Fusion Inhibitors and Integrase inhibitors have been documented to cause adverse effects in patients…
have become targets for ART. However, as in the case for other drug classes, Integrase Inhibitor Resistance-Associated Mutations (INI- RAMs) and mutations resulting in HIV-1 co-receptor tropism ... with D/M tropism)…
studies to elucidate structural basis for the mode of action of clinically used integrase strand transfer inhibitors (INSTIs), which bind to the enzyme active site in the context ... strand transfer reaction. Our…
HIV-1 integrase (IN) catalyzes chromosomal integration of synthesized viral DNA into
This compilation highlights current research in HIV-1, focusing on novel therapeutic agents like integrase inhibitors and broadlyneutralizing antibodies. It examines host immune responses in elite controllers, the…
Integrase (IN) inhibitors are the most recently developed class of antiretroviral agents with raltegravir, elvitegravir and dolutegravir being approved by the FDA. However, the emergence of drug-resistant IN mutants
Objective: To describe the ARV resistance profiles of patients experiencing virological failure
The HIV-1 epidemic continues around the world, but also in the
A rapid, specific and accurate high performance liquid chromatographic method for the
High mortality rate of Ebola infections and less therapeutic options baffle the
NNRTIs), Protease Inhibitors (PIs), Fusion Inhibitors (FIs), post attachment inhibitors, co-receptor (CCR5/CXCR4) inhibitor, Integrase Inhibitors (INIs) and pharmacokinetic enhancer. They are targeting critical steps…
For authors and organisers
Find the right journal for your paper and submit your manuscript.